Genotyping of the platelet-specific alloantigen HPA-5 (Br(a)/Br(b)) using polymerase chain reaction with sequencespecific primers (PCR-SSP). 1996

M Hou, and L Rosengren-Kogan, and B Forsberg, and A Elmgren, and L Rydberg, and J Kutti, and H Wadenvik
Department of Medicine, Sahlgrenska Hospital, University of Göteborg, Sweden.

A DNA-based one-stage technique, polymerase chain reaction with sequence-specific primers (PCR-SSP) was developed for genotyping of the platelet specific alloantigen HPA-5 (Bra/Brb). Sequence-specific primers, matching the wild type and the point mutation responsible for the HPA-5 (Bra/Brb) phenotype, were constructed. Conjointly a fragment of the gene coding for glycoprotein (GP) IIIa was amplified as an internal control of the enzyme reaction. Using these HPA-5 (Bra/Brb) sequence-specific primers the correct fragment of the GPIa gene was amplified, as evidenced by the PCR product size, the restriction map and by the nucleotide sequence. This assay was applied on 187 Swedish blood donors; 157 individuals were found to have a homozygous HPA-5a (Bra/Brb) genotype and 30 individuals a heterozygous HPA-5a,b (Bra/Brb) genotype. None of the donors was found to display a homozygous HPA-5b (Bra/Brb) genotype. Thus, the (HPA-5b) Bra antigen frequency in this population will be approximately 16.0% with a gene frequency of 8.0%. It is concluded that this assay is an attractive technique for genotyping of the HPA-5 (Bra/Brb) alloantigens on genomic DNA. The technique can replace serological alloantigen typing, especially in cases where platelets and rare human alloantisera are not available.

UI MeSH Term Description Entries
D007519 Isoantigens Antigens that exist in alternative (allelic) forms in a single species. When an isoantigen is encountered by species members who lack it, an immune response is induced. Typical isoantigens are the BLOOD GROUP ANTIGENS. Alloantigens,Alloantigen,Isoantigen
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain

Related Publications

M Hou, and L Rosengren-Kogan, and B Forsberg, and A Elmgren, and L Rydberg, and J Kutti, and H Wadenvik
October 1995, Forensic science international,
M Hou, and L Rosengren-Kogan, and B Forsberg, and A Elmgren, and L Rydberg, and J Kutti, and H Wadenvik
February 1996, Acta medica Okayama,
M Hou, and L Rosengren-Kogan, and B Forsberg, and A Elmgren, and L Rydberg, and J Kutti, and H Wadenvik
January 1994, Transfusion,
M Hou, and L Rosengren-Kogan, and B Forsberg, and A Elmgren, and L Rydberg, and J Kutti, and H Wadenvik
June 2021, Iranian journal of allergy, asthma, and immunology,
M Hou, and L Rosengren-Kogan, and B Forsberg, and A Elmgren, and L Rydberg, and J Kutti, and H Wadenvik
March 1995, Tissue antigens,
M Hou, and L Rosengren-Kogan, and B Forsberg, and A Elmgren, and L Rydberg, and J Kutti, and H Wadenvik
November 1994, British journal of haematology,
M Hou, and L Rosengren-Kogan, and B Forsberg, and A Elmgren, and L Rydberg, and J Kutti, and H Wadenvik
January 2000, Tissue antigens,
M Hou, and L Rosengren-Kogan, and B Forsberg, and A Elmgren, and L Rydberg, and J Kutti, and H Wadenvik
September 1996, Blood,
M Hou, and L Rosengren-Kogan, and B Forsberg, and A Elmgren, and L Rydberg, and J Kutti, and H Wadenvik
September 1999, Tissue antigens,
M Hou, and L Rosengren-Kogan, and B Forsberg, and A Elmgren, and L Rydberg, and J Kutti, and H Wadenvik
January 2004, American journal of human biology : the official journal of the Human Biology Council,
Copied contents to your clipboard!